Latest Story
Civica to produce lower-cost insulin
Civica Rx, a nonprofit generic drug-maker with a pharmaceutical manufacturing plant under construction in Petersburg, plans to produce three forms of insulin priced at $30 per vial beginning in early 2024, a project that dovetails with a bill in Congress that would cap consumers’ out-of-pocket insulin costs. Civica’s 140,000-square-foot, $124.5 million Petersburg production facility will
More Stories
AMPAC expanding Petersburg operation, adding 156 jobs
Pharmaceutical manufacturer plans to invest $25 million
Published
AMPAC Fine Chemicals plans to grow its Petersburg manufacturing facility, investing $25 million and creating 156 jobs, Gov. Ralph Northam announced Tuesday. AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner with Richmond-based Phlow Corp., Virginia Commonwealth University’s Medicines for All Institute and nonprofit drugmaker Civica Inc., on a federally funded, $354 million contract